Peggy Manders

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 604 citations · Full text

Medicine, Biostatistics, Oncology +15

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Antonis C. Antoniou, Amanda B. Spurdle, Olga M. Sinilnikova et al. · The American Journal of Human Genetics · 2008 · 284 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

Anouk Pijpe, Nadine Andrieu, D. F. Easton et al. · BMJ · 2012 · 232 citations · Full text

Medicine, Oncology, Radiation Oncology +17

High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer

Peter Bult, Louise M. de Widt-Levert, L.V.A.M. Beex et al. · Journal of Clinical Oncology · 2002 · 147 citations · Full text

Medicine, Oncology, Pathology +16

Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer

Paul N. Span, Peggy Manders, J.J.T.M. Heuvel et al. · Oncogene · 2002 · 133 citations

Medicine, Molecular Genetics, Oncology +13